Gunshot Injuries Treatment Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

Gunshot Injuries Treatment Market Report Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
 
SEATTLE - April 1, 2021 - PRLog -- The Global Gunshot Injuries Treatment Market was valued at US$ 6.9 million in 2015 and is projected to exhibit a CAGR of 8.2% over the forecast period (2017–2025). Technological developments such as innovative pocket sized device, which use tiny sponges and emergency treatment in the battlefield for soldiers, are expected to be major factors driving growth of the global gunshot injuries treatment market over the foreseeable future. Efficient treatment by products that prevent postpartum hemorrhage to boost the gunshot injuries treatment market Postpartum hemorrhage (PPH) is the leading cause of maternal mortality in low-income countries, and responsible for a quarter of all maternal deaths globally.

According to an article published by Medscape, pregnancy-related mortality ratio was estimated to be 17.3 deaths per 100,000 pregnant women, with around 11.4% of these deaths caused due by postpartum hemorrhage, in 2013. The initiatives taken by organizations such as the United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the UK Government to aid research for the development of preventive devices for PPH is a major factor causing expansion of the gunshot injuries treatment market.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/772

Furthermore, the development of the XSTAT-PPH device by Oregon Health & Science Univsersity and RevMedx for the treatment of postpartum hemorrhage (PPH) in low resource settings accelerates growth of the gunshot injuries treatment market.

Surgical priorities for prevention of gunshot management includes hemorrhage control, prevention, and reconstruction of infection, as gunshot has potential to damage affected tissues. The Xstat syringe was the only FDA-approved device for immediate treatment of blood flow.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/gunshot-injuries-treatment-market-772

Key takeaways of the Gunshot Injuries Treatment Market:

The global gunshot injuries treatment market is expected to exhibit a CAGR of 8.2% over the forecast period, with economies in Asia Pacific, Latin America, Middle East, and Africa focusing on increasing their military spending.

The Xstat is the dominant product segment in the market, as this portable device provides emergency treatment for soldiers in the battlefield

RevMedx, Inc currently is the only player involved in the global gunshot injuries treatment market.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/772

Contact
Mr. Shah
sales@coherentmarketinsights.com
+1-206-701-6702
End
Email:***@coherentmarketinsights.com
Posted By:***@coherentmarketinsights.com Email Verified
Tags:Healthcare
Industry:Health
Location:Seattle - Washington - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Coherent Market Insights PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share